Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer
Abstract Proteasomes are multi-subunit complexes that specialize in protein degradation. Cancer cells exhibit a heightened dependence on proteasome activity, presumably to support their enhanced proliferation and other cancer-related characteristics. Here, a systematic analysis of TCGA breast cancer...
Main Authors: | Holly A. Byers, Amy N. Brooks, Janakiram R. Vangala, Jacqueline M. Grible, Alex Feygin, Charles V. Clevenger, J. Chuck Harrell, Senthil K. Radhakrishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-43121-x |
Similar Items
-
BET Inhibitors Synergize with Carfilzomib to Induce Cell Death in Cancer Cells via Impairing Nrf1 Transcriptional Activity and Exacerbating the Unfolded Protein Response
by: Janakiram R. Vangala, et al.
Published: (2020-03-01) -
Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer
by: Alicia E. Woock, et al.
Published: (2021-06-01) -
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity
by: Frederick M. Tomlin, et al.
Published: (2017-10-01) -
p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition
by: Senthil K Radhakrishnan, et al.
Published: (2014-01-01) -
Mutant p53–Nrf2 axis regulates the proteasome machinery in cancer
by: Kamil Lisek, et al.
Published: (2017-01-01)